Independent Financial Group LLC Buys Shares of 14,835 Lam Research Corporation $LRCX

Independent Financial Group LLC purchased a new position in Lam Research Corporation (NASDAQ:LRCX) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 14,835 shares of the semiconductor company’s stock, valued at approximately $3,170,000.

Several other hedge funds also recently made changes to their positions in LRCX. Cedar Mountain Advisors LLC lifted its holdings in Lam Research by 242.9% during the 1st quarter. Cedar Mountain Advisors LLC now owns 120 shares of the semiconductor company’s stock worth $26,000 after purchasing an additional 85 shares in the last quarter. Vermillion Wealth Management Inc. purchased a new position in Lam Research during the 1st quarter valued at about $26,000. PMV Capital Advisers LLC bought a new stake in shares of Lam Research during the fourth quarter valued at about $25,000. Bayban bought a new stake in shares of Lam Research during the fourth quarter valued at about $26,000. Finally, Mcguire Capital Advisors Inc. purchased a new stake in shares of Lam Research in the fourth quarter worth about $27,000. 84.61% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Lam Research

In related news, SVP Neil J. Fernandes sold 7,659 shares of the firm’s stock in a transaction dated Monday, June 1st. The stock was sold at an average price of $309.60, for a total transaction of $2,371,226.40. Following the transaction, the senior vice president directly owned 58,470 shares of the company’s stock, valued at approximately $18,102,312. This trade represents a 11.58% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Eric Brandt sold 54,500 shares of the business’s stock in a transaction that occurred on Thursday, June 11th. The stock was sold at an average price of $350.80, for a total value of $19,118,600.00. Following the completion of the sale, the director owned 199,205 shares of the company’s stock, valued at $69,881,114. The trade was a 21.48% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders sold 104,621 shares of company stock worth $33,804,737. 0.31% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on the stock. Stifel Nicolaus raised their price objective on shares of Lam Research from $325.00 to $425.00 and gave the company a “buy” rating in a research report on Friday, July 10th. Evercore upped their target price on shares of Lam Research from $275.00 to $300.00 and gave the stock an “outperform” rating in a report on Thursday, April 23rd. Needham & Company LLC increased their target price on shares of Lam Research from $300.00 to $390.00 and gave the stock a “buy” rating in a research note on Friday, July 10th. The Goldman Sachs Group reissued a “buy” rating and issued a $290.00 price target on shares of Lam Research in a report on Thursday, April 23rd. Finally, Morgan Stanley boosted their price target on shares of Lam Research from $331.00 to $404.00 and gave the company an “overweight” rating in a research report on Monday, July 6th. Twenty-eight equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $358.67.

Lam Research Price Performance

Shares of NASDAQ:LRCX opened at $313.30 on Friday. The company’s fifty day moving average price is $339.57 and its 200-day moving average price is $268.94. The company has a debt-to-equity ratio of 0.35, a current ratio of 2.54 and a quick ratio of 1.77. The firm has a market capitalization of $391.80 billion, a price-to-earnings ratio of 59.11, a PEG ratio of 1.90 and a beta of 1.80. Lam Research Corporation has a one year low of $90.93 and a one year high of $438.50.

Lam Research (NASDAQ:LRCX) last posted its quarterly earnings data on Wednesday, April 22nd. The semiconductor company reported $1.47 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.36 by $0.11. Lam Research had a net margin of 30.94% and a return on equity of 66.21%. The company had revenue of $5.84 billion during the quarter, compared to the consensus estimate of $5.70 billion. During the same period in the previous year, the firm posted $1.04 EPS. The firm’s revenue was up 23.8% compared to the same quarter last year. Lam Research has set its Q4 2026 guidance at 1.500-1.800 EPS. On average, equities research analysts anticipate that Lam Research Corporation will post 5.68 earnings per share for the current fiscal year.

Lam Research Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, July 8th. Shareholders of record on Wednesday, June 17th were given a dividend of $0.26 per share. The ex-dividend date was Wednesday, June 17th. This represents a $1.04 dividend on an annualized basis and a yield of 0.3%. Lam Research’s dividend payout ratio (DPR) is presently 19.62%.

Lam Research Profile

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.